You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NPP

Showing 1 - 25 of 260
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ingaron in Volunteers for the Prevention of COVID-19

Completed
  • COVID-19 Respiratory Infection
  • Interferon gamma human recombinant (IFN-G)
  • Moscow, Russian Federation
    City Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 20, 2022

Primary Mitochondrial Disease Trial in Germany, Italy (OMT-28)

Recruiting
  • Primary Mitochondrial Disease
  • Bonn, Germany
  • +5 more
Aug 3, 2023

Substance Abuse, Substance Use, Child Abuse Trial in Columbus (Peer Recovery Support, Family Treatment Drug Court with

Recruiting
  • Substance Abuse
  • +3 more
  • Peer Recovery Support
  • +2 more
  • Columbus, Ohio
    The Ohio State University
Sep 14, 2021

Previously Treated Advanced/Metastatic HER2-positive Breast

Recruiting
  • HER2-positive Breast Cancer
  • Trastuzumab deruxtecan
  • Naples, Italy
  • +17 more
Jan 31, 2023

Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient

Completed
  • Chronic Lymphocytic Leukemia
  • Ascoli Piceno, Italy
  • +46 more
Sep 6, 2021

Community-acquired Pneumonia Trial in Moscow (Interferon-Gamma)

Completed
  • Community-acquired Pneumonia
  • Moscow, Russian Federation
    City Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 24, 2022

Trial (Olverembatinib)

Available
    • (no location specified)
    Nov 10, 2022

    Flatfoot, Flexible, Pes Valgus, Pes Varus Trial in Prague (Neurophysiology-based exercise program)

    Recruiting
    • Flatfoot, Flexible
    • +5 more
    • Neurophysiology-based exercise program
    • Prague, Czechia
      Faculty of Physical Education and Sport, Charles University
    Mar 22, 2023

    Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)

    Available
    • Pulmonary Hypertension
    • +2 more
    • Inhaled Treprostinil
    • (no location specified)
    Oct 5, 2022

    OCD Trial (Psilocybin)

    Recruiting
    • Obsessive-Compulsive Disorder
    • Baltimore, Maryland
      Johns Hopkins University School of Medicine
    Nov 28, 2022

    Breast Cancer, Oral Cancer Trial in Mumbai (Cannabis capsules)

    Active, not recruiting
    • Breast Cancer
    • Oral Cancer
    • Cannabis capsules
    • Mumbai, Maharashtra, India
    • +1 more
    Jul 22, 2023

    Schizophrenia, Schizoaffective Disorder, Bipolar Disorder Trial in Tacoma (olanzapine and melatonin)

    Active, not recruiting
    • Schizophrenia
    • +4 more
    • olanzapine and melatonin
    • Tacoma, Washington
      VA Puget Sound Health Care System
    Oct 6, 2022

    Depression, Postpartum, Anxiety Trial in Boston (Oxytocin, Placebo)

    Active, not recruiting
    • Depression, Postpartum
    • Anxiety
    • Boston, Massachusetts
      Massachusetts General Hosptial
    Jan 14, 2023

    Alcohol Use Disorders (AUD) Trial in Providence (Mifepristone 600-mg/day or for a week)

    Completed
    • Alcohol Use Disorders (AUD)
    • Mifepristone 600-mg/day or placebo for a week
    • Providence, Rhode Island
      Center for Alcohol and Addiction Studies, Brown University
    Jan 29, 2022

    Alcohol Use Disorder (AUD), Transcranial Magnetic Stimulation Trial in Palo Alto (Deep Transcranial Magnetic Stimulation (dTMS)

    Recruiting
    • Alcohol Use Disorder (AUD)
    • Transcranial Magnetic Stimulation
    • Deep Transcranial Magnetic Stimulation (dTMS) H7 coil
    • Palo Alto, California
      VA Palo Alto Health Care System
    Oct 24, 2022

    Substance Use Disorders Trial in Ankara (Balance Exercises (BE), BE + Dual Task)

    Recruiting
    • Substance Use Disorders
    • Balance Exercises (BE)
    • BE + Dual Task
    • Ankara, Turkey
      Ankara Yildirim Beyazit University, Faculty of Health Sciences,
    Jul 6, 2023

    MMRR Treated With Belantamab Mafotidine on Monotherapy

    Not yet recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • (no location specified)
    May 23, 2022

    Behavioral and Psychiatric Symptoms of Dementia, Insomnia Trial in Pennsauken (Recommendation to Deprescribe)

    Withdrawn
    • Behavioral and Psychiatric Symptoms of Dementia
    • Insomnia
    • Recommendation to Deprescribe
    • Pennsauken, New Jersey
      Trinity Health LIFE, New Jersey
    May 18, 2022

    Anorexia Nervosa Trial in San Francisco (Repetitive Transcranial Magnetic Stimulation (rTMS))

    Recruiting
    • Anorexia Nervosa
    • Repetitive Transcranial Magnetic Stimulation (rTMS)
    • San Francisco, California
      University of California, San Francisco
    Nov 21, 2023

    Reproductive Medicine Trial in Paris (standard care, specific treatment)

    Recruiting
    • Reproductive Medicine
    • standard care
    • specific treatment
    • Paris, France
      Hôpital Saint-Louis - Laboratoire MatriceLAb Innove
    Jun 10, 2022

    Inference in Sensory Preconditioning Task in Opioid-Use Disorder

    Recruiting
    • Opioid-Related Disorders
    • Drug Addiction
      • Baltimore, Maryland
        National Institute on Drug Abuse
      Aug 17, 2022

      Schizophrenia Trial in Phoenix (Ziprasidone, Olanzapine, Placebo Comparator)

      Recruiting
      • Schizophrenia
      • Phoenix, Arizona
      • +1 more
      Feb 23, 2022

      Ovarian Cancer Trial in Beijing (Manganese Chloride, nab-paclitaxel, Platinum chemo)

      Recruiting
      • Ovarian Cancer
      • Manganese Chloride
      • +3 more
      • Beijing, Beijing, China
        Biotherapeutic Department of Chinese PLA General Hospital
      Dec 20, 2020

      Depression, Anxiety, Stress Trial in Abbottabad (Lemon Balm Supplement, Matched Placebo)

      Recruiting
      • Depression
      • +3 more
      • Lemon Balm Supplement
      • Matched Placebo
      • Abbottābād, Pakistan
        Ayub Teaching Hospital
      Jan 4, 2023

      Treatment Resistant Depression Trial (Sequential bilateral theta burst stimulation)

      Not yet recruiting
      • Treatment Resistant Depression
      • Sequential bilateral theta burst stimulation
      • (no location specified)
      Mar 30, 2023